Adverse drug reactions |
|
L01X |
12,240 (22.3%) |
Irinotecan (2,994, 5.5%), oxaliplatin (2,789, 5.1%), rituximab (1,508, 2.8%), cisplatin (1,257, 2.3%), carboplatin (1,045, 1.9%), trastuzumab (368, 0.7%), L-asparaginase (256, 0.5%), gefitinib (254, 0.5%), topotecan (158, 0.3%), cetuximab (157, 0.3%), sorafenib (145, 0.3%) |
J04A |
6,059 (11.1%) |
Pyrazinamide (1,700, 3.1%), isoniazid (1,654, 3.0%), ethambutol (1,628, 3.0%), rifampicin (898, 1.6%) |
L01C |
5,634 (10.3%) |
Docetaxel (2,659, 4.9%), paclitaxel (1,381, 2.5%), etoposide (810, 1.5%), vincristine (492, 0.9%), vinblastine (148, 0.3%), vinorelbine (140, 0.3%) |
J01D |
3,825 (7.0%) |
Cefazolin (741, 1.4%), ceftriaxone (526, 1.0%), meropenem (400, 0.7%), cefotetan (383, 0.7%), cefotaxime (238, 0.4%), cefepime (212, 0.4%), cefaclor (177, 0.2%), flomoxef (144, 0.2%) |
L01B |
3,571 (5.8%) |
Cytarabine (769, 1.4%), fluorouracil (638, 1.2%), methotrexate (572, 1.0%), capecitabine (555, 1.0%), gemcitabine (466, 0.9%), fludarabine (183, 0.3%), pemetrexed (134, 0.2%) |
N02A |
3,180 (5.8%) |
Tramadol (774, 1.4%), fentanyl (467, 0.9%), pethidine (446, 0.8%), tramadol and paracetamol (435, 0.8%), morphine (403, 0.7%), oxycodone (205, 0.4%) |
J01X |
2,510 (4.5%) |
Vancomycin (1,694, 3.1%), metronidazole (322, 0.6%), teicoplanin (290, 0.5%), linezolid (124, 0.2%) |
N01A |
2,469 (4.5%) |
Fentanyl (2,163, 3.9%), ketamine (207, 0.4%), thiopental (49, 0.01%), remifentanil (20, 0.03%), propofol (20, 0.03%) |
J01C |
2,322 (4.2%) |
Piperacillin/tazobactam (1,491, 2.7%), amoxicillin/clavulanate (241, 0.4%), amoxicillin (186, 0.3%), ampicillin/sulbactam (130, 0.2%) |
M01A |
1,897 (3.5%) |
Ibuprofen (460, 0.8%), ketorolac (275, 0.5%), celecoxib (201, 0.4%), aceclofenac (170, 0.3%), propionic acid derivatives (145, 0.3%), diclofenac (124, 0.2%), naproxen (107, 0.2%) |
Serious adverse events |
|
L01X |
886 (16.1%) |
Oxaliplatin (207, 3.8%), rituximab (138, 2.5%), carboplatin (125, 2.3%), cisplatin (100, 1.8%), L-asparaginase (50, 0.9%), irinotecan (41, 0.7%), cetuximab (32, 0.6%) |
J01D |
503 (9.1%) |
Cefaclor (83, 1.5%), cefazolin (55, 1.0%), meropenem (55, 1.0%), ceftriaxone (43, 0.8%), cefotaxime (34, 0.6%), cefepime (33, 0.6%), cefotetan (26, 0.5%) |
L01C |
472 (8.6%) |
Etoposide (128, 2.3%), paclitaxel (123, 2.2%), docetaxel (104, 1.9%), vincristine (86, 1.6%), vinblastine (21, 0.4%) |
J01X |
454 (8.2%) |
Vancomycin (339, 6.1%), teicoplanin (43, 0.8%), linezolid (39, 0.7%), colistin (19, 0.3%) |
J04A |
381 (6.9%) |
Rifampicin (114, 2.0%), isoniazid (104, 1.9%), ethambutol (82, 1.5%), pyrazinamide (64, 1.2%) |
L01B |
364 (6.6%) |
Cytarabine (115, 2.0%), methotrexate (86, 1.6%), fluorouracil (45, 0.8%), gemcitabine (38, 0.7%), fludarabine (29, 0.5%) |
J01C |
318 (5.8%) |
Piperacillin/tazobactam (190, 3.4%), amoxicillin/clavulanate (31, 0.6%), amoxicillin (27, 0.5%), nafcillin (17, 0.3%) |
N03A |
307 (5.6%) |
Carbamazepine (73, 1.3%), valproate (63, 1.1%), oxcarbazepine (34, 0.6%), lamotrigine (30, 0.5%), phenytoin (21, 0.4%) |
M01A |
292 (5.3%) |
Ketorolac (60, 1.0%), ibuprofen (42, 0.8%), diclofenac (35, 0.6%), dexibuprofen (33, 0.6%), aceclofenac (22, 0.4%), naproxen (20, 0.4%) |
L01A |
280 (5.1%) |
Cyclophosphamide (110, 2.0%), busulfan (78, 1.4%), ifosfamide (39, 0.7%), melphalan (22, 0.4%), thiotepa (18, 0.3%) |